Search
forResearch 10 of 1000+
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer
- Lipid-based liquid crystals as drug delivery vehicles for antimicrobial peptides
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Molecular elements of the regulatory control of keratin filament modulator AHF/trichohyalin in the hair follicle
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
Learn 1
Community
— no results
Try a deeper search in community →